GSK's consumer health spinout Haleon started ... a decade – has annual sales of around £10 billion from brands like Sensodyne toothpaste, Voltaren and Panadol painkillers, and Centrum ...

Sensodyne's brand purpose is to create an oral care future that is sensitivity‐free; we wanted to create a mobile-first digital experience that would help the brand achieve this goal. While the legacy ...

GSK sold its remaining stake in May last year ... The business saw operating profit rise 10.5% to £2.5bn although revenue slipped 0.6% to £11.2bn. Brands like Sensodyne toothpaste and Centrum ...

Haleon--which owns brands such as Sensodyne toothpaste, Aquafresh mouthwash and over-the-counter medicines Panadol and Advil--was formed in July 2019 through the merger of GSK and Pfizer's ...

Like other fast-food brands GDK faces scrutiny from nanny-state ... the FTSE100 maker of Sensodyne toothpaste and Panadol painkillers. Pfizer raised £2.4billion from its 618million shares at ...

Pfizer PFE has sold off its remaining stake in consumer health company Haleon HLN to institutional investors and Haleon itself for around $3.3 billion. Pfizer sold its 7.3% stake in Haleon, or ...

His replacement, finance boss Fernando Fernandez, is tasked with revitalising a company with a so-so portfolio of brands ... Australia and the Middle East. GSK shares jump on $2.2 billion Zantac ...

Haleon, known for brands like Sensodyne, emerged from Pfizer and GSK’s combined consumer units in 2022 and ... Haleon’s CEO brushed off potential US tariff impacts, humorously implying that toothpaste ...